RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 111 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2015. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $982,000 | +67.0% | 109,460 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $588,000 | +16.7% | 109,460 | 0.0% | 0.00% | – |
| Q1 2016 | $504,000 | -20.0% | 109,460 | -9.7% | 0.00% | -100.0% |
| Q4 2015 | $630,000 | -14.1% | 121,160 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $733,000 | -61.7% | 121,160 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $1,915,000 | +60.8% | 121,300 | +10.7% | 0.00% | +100.0% |
| Q1 2015 | $1,191,000 | +3.3% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,153,000 | +9.7% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,051,000 | -17.0% | 109,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,266,000 | +15.3% | 109,600 | -0.2% | 0.00% | 0.0% |
| Q1 2014 | $1,098,000 | -23.1% | 109,837 | +0.2% | 0.00% | 0.0% |
| Q4 2013 | $1,427,000 | -11.6% | 109,600 | +1.4% | 0.00% | -50.0% |
| Q3 2013 | $1,615,000 | +159.2% | 108,100 | +62.1% | 0.00% | +100.0% |
| Q2 2013 | $623,000 | – | 66,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |